PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of anngastLink to Publisher's site
 
Ann Gastroenterol. 2016 Jul-Sep; 29(3): 241–242.
Published online 2016 May 20. doi:  10.20524/aog.2016.0048
PMCID: PMC4923808

Celiac-associated pancreatic disease

Pancreatic disease may be caused by or co-exist with celiac disease. In this setting, endocrine and exocrine changes may occur. As a result, superimposed, severe clinical changes with marked nutritional alteration may result. Importantly, however, in some, endocrine and exocrine pancreatic function may be improved with a gluten-free diet.

Early studies from Europe and the Americas have shown that celiac disease patients have an increased prevalence rate of type 1 diabetes mellitus [1-4]. In part, this relationship was possibly due to sharing of the human leukocyte antigen alleles, DR3, and by linkage disequilibrium, DQ2 [5]. Besides this hypothesized common “immune-mediated” etiopathogenesis, some celiacs with pancreatic disease likely have developed diabetic changes secondarily due to severe exocrine pancreatic failure, in part, related to celiac-induced protein malnutrition.

To further evaluate the prevalence rate of type 1 diabetes in celiac disease, prospective studies using an initial screening IgA tissue transglutaminase antibody assay (tTG) were done at our center in children and adolescents with type 1 diabetes mellitus [6]. A total of 125 male and 108 female patients were evaluated from an established pediatric diabetes clinic. Of these, 15 male and 11 female patients had elevated tTG titers, of whom 19 were also positive for endomysial antibodies. Among these cases, 1 was already known to have celiac disease. Small intestinal biopsies were done in the other 18 children positive for both antibodies. In all, histopathological changes consistent with celiac disease were detected, ranging from increased numbers of intraepithelial lymphocytes to severe crypt hyperplastic villous atrophy (i.e., so-called Marsh 3 lesion). Studies also suggested that serial tTG titers in insulin-dependent diabetic children might play a useful clinical role in monitoring compliance to a gluten-free diet, possibly of value since close monitoring of compliance of children to a gluten-free diet may be exceedingly difficult. In this study, over 40% of diabetic children were asymptomatic, and yet, prospective serological screening facilitated selection for small intestinal biopsy evaluation. Overall, 7.7% of this entire pediatric patient population proved to have typical biopsy features of celiac disease. Remarkably, this rate was confirmed in a more recent European study, published almost a decade later, showing tTG positivity in 8.6% of diabetic children and adolescents, many again asymptomatic or having non-specific or mild gastrointestinal symptoms [7].

Earlier detection of celiac disease, even in children, with type 1 diabetes is important because of the increased risk for long-term consequences of untreated celiac disease. Most troublesome is the appearance of enteropathy-associated T-cell lymphoma, a disorder that may be reduced in its rate of appearance with a gluten-free diet [8]. Interestingly, 4 cases of lymphoma, celiac disease and type 1 diabetes have been described [9].

Other long-term issues may develop including iron deficiency anemia, osteopenic bone disease, infertility and impaired growth. Poor dietary compliance and delayed diagnosis into later life may be important factors. Improved glucose control with a gluten-free diet has also been noted in type 1 diabetes and concomitant celiac disease [10].

Pancreatic exocrine function may also be significantly changed in celiac disease. Impaired pancreatic function may result in impaired digestion and absorption of critical nutrients along with resultant malnutrition [11]. Logically, in some of these, it is believed that this impairment in nutrition may be made more severe than if only celiac disease alone was present. Some have estimated that up to 20% or more of celiac patients have defective pancreatic function [12]. In part, this may be due to impaired release of gut-derived peptides crucial to a well-regulated assimilative absorptive process because of mucosal endocrine cell loss. Loss of enteric endocrine cells, including secretin cells [13], have been demonstrated.

Test meal studies in celiac disease have suggested impaired cholecystokinin-pancreozymin secretion leading to a reduction in pancreatic exocrine cell stimulation [14]. Deficiencies of amino acids may result from impaired small intestinal uptake of amino acids (and possibly, small peptides) in some with celiac disease [12,15]. Conceivably, this could lead to reduced production of pancreatic enzyme precursors, important for normal pancreatic enzyme hydrolytic activity [15]. Also, altered pancreatic structure may be caused by protein malnutrition including atrophy and fibrosis of the pancreas [11]. Measurements of pancreatic enzyme activities may be reduced with mucosal atrophy and levels were inversely related to the degree of intestinal mucosal damage [16]. In some, severe structural changes of the pancreas have been described, including pancreatic calcification, often associated with chronic or persisting pancreatic inflammation and traditionally associated with excessive use of alcohol. However, protein energy malnutrition appears to be independently associated with kwashiorkor and some patients with celiac disease have shown similar features [17,18]. In one celiac with pancreatic calcification [18], detailed follow up of intestinal biopsies over several years revealed a prolonged period, albeit, eventual mucosal recovery in spite of a prolonged and strict gluten-free diet alone.

Prior studies have documented increased serum amylase levels in about 25% of patients raising the possibility of a low-grade pancreatic inflammatory process [19]. Later, in a more recent evaluation [20], exocrine pancreatic function in celiac disease was explored by measuring fecal elastase-1 concentrations along with magnetic resonance imaging (MRI) to evaluate pancreatic structure for morphological changes. Using these methods, 4 of 90 celiacs, or 4.4%, had evidence of pancreatic insufficiency (1 mild, 3 severe) while MRI was normal in all 4 of these celiac patients. In a retrospective survey of hospital diagnostic coding from Sweden, a 3-fold increased rate of pancreatitis (from any cause) in celiac disease patients was noted (i.e., 406 of 28908 celiacs) [21]. In contrast, a study from India published in this issue of the Annals of Gastroenterology [22] documents exocrine pancreatic insufficiency in 10 of 36, or about one-third of young adults (mean age, less than 30 years) based on fecal elastase determinations. Of these, over 80% showed reversal of elevated fecal elastase values on a gluten-free diet. Most had moderate to severely abnormal small bowel biopsies (i.e., Marsh 2-3C) and only 1 had recurrent bouts of acute pancreatitis. Structural changes based on imaging studies were rarely encountered. Further longer-term studies are now needed to determine if these potentially important observations can be verified by other centers.

Biography

• 

University of British Columbia, Vancouver, BC, Canada

Footnotes

Conflict of Interest: None

References

1. Saukkonen T, Savilahti E, Reijonen H, Ilonen J, Tuomilehto-Wolf E, Akerblom HK. Celiac disease:frequent occurrence after clinical onset of insulin-dependent diabetes mellitus. Childhood Diabetes in Finland Study Group. Diabet Med. 1996;13:464–470. [PubMed]
2. Maki M, Huupponen T, Holm K, Hallstrom O. Seroconversion of reticulin autoantibodies predicts celiac disease in insulin dependent diabetes. Gut. 1995;36:239–242. [PMC free article] [PubMed]
3. Fraser-Reynolds KA, Butzner JD, Stephure DK, Trusssell RA, Scott RB. Use of immunoglobulin A-antiendomysial antibody to screen for celiac disease in North American children with type 1 diabetes. Diabetes Care. 1998;21:1985–1989. [PubMed]
4. Hill I, Fasano A, Schwartz R, Counts D, Glock M, Horvath K. The prevalence of celiac disease in at-risk groups of children in the United States. J. Pediatr. 2000;136:86–90. [PubMed]
5. Lie BA, Sollid LM, Ascher H, et al. A gene telomeric of the HLA class I region involved predisposition to both type 1 diabetes and celiac disease. Tissue Antigens. 1999;54:162–168. [PubMed]
6. Gillett PM, Gillett HR, Israel DM, et al. High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase. Can J Gastroenterol. 2001;15:297–301. [PubMed]
7. Kakleas K, Karayianni C, Critselis E, et al. The prevalence and risk factors of celiac disease among children and adolescents with type 1 diabetes mellitus. Diabetes Res Clin Pract. 2010;90:202–208. [PubMed]
8. Holmes GK, Prior P, Lane MR, Pope D, Allan RN. Malignancy in celiac disease-effect of a gluten- free diet. Gut. 1989;30:333–338. [PMC free article] [PubMed]
9. O’Connor TM, Cronin CC, Loane JF, et al. Type 1 diabetes, celiac disease, and lympohoma:a report of four cases. Diabet Med. 1999;16:614–617. [PubMed]
10. Acerini CL, Ahmed ML, Ross KM, Sullivan PB, Bird G, Dunger DB. Celiac disease in children and adolescents with IDDM:clinical characteristics and response to gluten-free diet. Diabet Med. 1998;15:38–44. [PubMed]
11. Freeman HJ, Kim YS, Sleisenger MH. Protein digestion and absorption in man. Normal mechanisms and protein-energy malnutrition. Am J Med. 1979;67:1030–1036. [PubMed]
12. Corroccio A, Iacono G, Montalto G, et al. Exocrine pancreatic function in children with celiac disease before and after a gluten free diet. Gut. 1991;32:796–799. [PMC free article] [PubMed]
13. Buchan AM, Grant S, Brown JC, Freeman HJ. A quantitative study of enteric endocrine cells in celiac sprue. J Pediatr Gastroenterol Nutr. 1984;3:665–671. [PubMed]
14. Regan PT, DiMagno EP. Exocrine pancreatic insufficiency in celiac sprue:a cause of treatment failure. Gastroenterology. 1980;78:484–487. [PubMed]
15. Weinstein LD, Herskovic T. Rectal seepage of oil in a patient with celiac disease and secondary pancreatic insufficiency. Am J Dig Dis. 1968;13:762–765. [PubMed]
16. Nousias-Arvanitakis S, Karagiozoglou-Lamboudes T, Aggouridaki C, Malaka-Lambrellis E, Calli-Tsinopoulou A, Xefteri M. Influence of jejunal morphology changes on pancreatic function in celiac disease. J Pediatr Gastroenterol Nutr. 1999;29:81–85. [PubMed]
17. Pitchumoni CS, Thomas E, Balthazar E, Sherling B. Chronic calcific pancreatitis in association with celiac disease. Am J Gastroenterol. 1977;68:358–361. [PubMed]
18. Freeman HJ, Whittaker JS. Nonalcoholic chronic pancreatitis with pancreatic calcification:presenting manifestation of occult celiac disease. Can J Gastroenterol. 1994;8:319–322.
19. Carroccio A, Di Prima L, Scalici C, et al. Unexplained elevated serum pancreatic enzymes:a reason to suspect celiac disease. Clin Gastroenterol Hepatol. 2006;4:455–459. [PubMed]
20. Vujasinovic M, Tepes B, Volfand J, Rudolf S. Exocrine pancreatic insufficiency, MRI of the pancreas and serum functional markers in patients with celiac disease. Postgrad Med J. 2015;91:497–500. [PubMed]
21. Sadr-Azodi O, Sanders DS, Murray JA, Ludvigsson JF. Patients with celiac disease have an increased risk for pancreatitis. Clin Gastroenterol Hepatol. 2012;10:1136–1142. [PMC free article] [PubMed]
22. Rana SS, Dambalker A, Chhabra P, et al. Pancreatic exocrine insufficiency in celiac disease:is it due to structural alterations in pancreatic parenchyma? Ann Gastroenterol. 2016;29:363–366.

Articles from Annals of Gastroenterology are provided here courtesy of The Hellenic Society of Gastroenterology